| 茹爱忠,刘静,蔡瑞君,曾秀琴,李娟,谢希辉.建立辅助用药预警监控干预体系对合理用药及新医改控费的作用[J].中国药事,2018,32(1):97-103 |
| 建立辅助用药预警监控干预体系对合理用药及新医改控费的作用 |
| The Role of Establishing an Early Warning and Intervention System of Adjuvant Drugs in Rational Drug Use and Cost Control in New Medical Reform |
| 投稿时间：2017-07-05 |
| DOI：10.16153/j.1002-7777.2018.01.017 |
| 中文关键词: 辅助用药 预警干预 合理用药 新医改控费 |
| 英文关键词: adjuvant drug early warning and intervention rational drug use cost control in new medical reform |
| 基金项目: |
|
| 摘要点击次数: 1550 |
| 全文下载次数: 893 |
| 中文摘要: |
| 目的：加强辅助用药的管控，促进医院合理用药，控制药品费用。方法：以“信息化网络质控”为依托，“辅助用药预警监控制度”为指导，“多元性药事干预”为措施，建立全方位、多角度辅助用药预警干预体系，考察干预前后辅助用药管控成效。结果：干预后酒泉市人民医院辅助用药销售金额较干预前下降了16.16%；排名前20位辅助用药销售金额均有不同程度的下降，总金额较干预前下降了18.67%；辅助用药使用频度（DDDs）也有明显变化；医院药占比由干预前的40.75%下降至35.98%；辅助用药销售占比由35.46%下降至31.32%。人均药品费用由干预前的（4701.24±1.41）元下降至（3674.45±2.09）元，人均辅助用药费用由（1629.20±0.86）元下降至（1050.01+1.02）元。结论：加强辅助用药的管理，对促进临床合理用药、提高用药安全性、控制药品费用，以及减轻患者就医负担具有重要意义。 |
| 英文摘要: |
| Objective: To strengthen the control of adjuvant drugs, to promote the rational drug use and to control drug costs. Methods: An comprehensive and multi-faceted adjuvant drug warning and intervention system was established based on "information network quality control", guided by "adjuvant drug warning and monitoring system", sustained by the measure of "diversified pharmacy intervention". The effectiveness of the control of adjuvant drugs before and after the intervention was analyzed. Results: After intervention, the sales of adjuvant drugs in our hospital decreased by 16.16% compared with those before intervention. The sales of top 20 adjuvant drugs decreased to various degrees. The total amount decreased by 18.67% compared with that before intervention. The defined daily dose system (DDDs) of adjuvant drugs also changed significantly. The proportion of hospital drugs decreased from 40.75% before intervention to 35.98%. The proportion of adjuvant drugs fell from 35.46% before intervention to 31.32%. The per capita drug cost dropped from 4701.24±1.41 yuan before intervention to 3674.45±2.09 yuan. The per capita adjuvant drug cost decreased from 1629.20±0.86 yuan before intervention to 1050.01+1.02 yuan. Conclusion: Strengthening the management of adjuvant drugs is of great significance for promoting clinical rational drug use, improving safety of medication, controlling drug costs and reducing financial burdens on patients. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |